Organization | AJ Vaccines A/S

AJ Vaccines A/S Report issue

For profit Phase 3 Phase 4

Founded: Denmark (2017)

Status: No NME R&D (2017)

Organization Overview

First Clinical Trial

2017

NCT03025750

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

AJ Vaccines A/S

Active Ingredients

Drugs in Phase 4 Trials (1)

ipv-al ssi (4 trials)

Drugs in Phase 3 Trials (1)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Poliomyelitis (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial APIs: 2